"Dose-dependent" Impact of Recurrent Cardiac Events on Mortality in Patients with Heart Failure

American Journal of Medicine

Volumn 122, Issue 2, 2009, Pages

  Lee, Douglas S ^a,b   Austin, Peter C ^a,c   Stukel, Thérèse A ^a,c   Alter, David A ^a,c,d   Chong, Alice ^a   Parker, John D ^b   Tu, Jack V ^a,c,e  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Department of Health Policy Management and Evaluation ^*  (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

heart failure; hospitalizations; mortality; outcomes research; prognosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SURVIVAL TIME;

AGED; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; RECURRENCE; RISK ADJUSTMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 58649104413     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.08.026     Document Type: Article

References (28)

1. Goldberg R.J., Ciampa J., Lessard D., Meyer T.E., and Spencer F.A. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med 167 (2007) 490-496
2. Krumholz H.M., Chen Y.T., Wang Y., et al. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 139 (2000) 72-77
3. Braunstein J.B., Anderson G.F., Gerstenblith G., et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42 (2003) 1226-1233
4. Chin M.H., and Goldman L. Correlates of early hospital readmission or death in patients with congestive heart failure. Am J Cardiol 79 (1997) 1640-1644
5. Rame J.E., Sheffield M.A., Dries D.L., et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J 142 (2001) 714-719
6. Tsuyuki R.T., McKelvie R.S., Arnold J.M., et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161 (2001) 2337-2342
7. Solomon S.D., Dobson J., Pocock S., et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 116 (2007) 1482-1487
8. Ahmed A., Allman R.M., Fonarow G.C., et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 14 (2008) 211-218
9. Lee D.S., Pencina M.J., Benjamin E.J., et al. Association of parental heart failure with risk of heart failure in offspring. N Engl J Med 355 (2006) 138-147
10. Lee D.S., Austin P.C., Rouleau J.L., et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
11. Lee D.S., Tu J.V., Juurlink D.N., et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 294 (2005) 1240-1247
12. Tu J.V., Bowen J., Chiu M., et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
13. Lee D.S., Donovan L., Austin P.C., et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 43 (2005) 182-188
14. International Classification of Diseases. Clinical Modification. 9th Revision (1988), Public Health Service, US Department of Health and Human Services, Washington, DC
15. International Statistical Classification of Diseases and Related Health Problems. 10th Revision (1992), World Health Organization, Geneva, Switzerland
16. Rosner B. Fundamentals of Biostatistics (2000), Duxbury, Belmont, CA
17. Kellett J. Prediction of mortality of patients with suspected heart failure by brain natriuretic peptide concentrations > 100 pg/ml: comparison of a clinical model with brain natriuretic peptide concentrations. Heart 92 (2006) 1512-1513
18. Ko D.T., Tu J.V., Masoudi F.A., et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med 165 (2005) 2486-2492
19. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113 (2006) 1424-1433
20. Rector T.S., Ringwala S.N., Ringwala S.N., and Anand I.S. Validation of a risk score for dying within 1 year of an admission for heart failure. J Card Fail 12 (2006) 276-280
21. Ko D.T., Alter D.A., Austin P.C., et al. Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J 155 (2008) 324-331
22. Hosmer D.W., and Lemeshow S. Applied Survival Analysis (1999), John Wiley and Sons, Inc, New York
23. Teuteberg J.J., Lewis E.F., Nohria A., et al. Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail 12 (2006) 47-53
24. Pocock S.J., Wang D., Pfeffer M.A., et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75
25. Pearte C.A., Furberg C.D., O'Meara E.S., et al. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study. Circulation 113 (2006) 2177-2185
26. Setoguchi S., Stevenson L.W., and Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154 (2007) 260-266
27. Garg R., and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: collaborative group on ACE inhibitor trials. JAMA 273 (1995) 1450-1456
28. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283 (2000) 1295-1302